vs

Side-by-side financial comparison of Clorox (CLX) and LESAKA TECHNOLOGIES INC (LSAK). Click either name above to swap in a different company.

LESAKA TECHNOLOGIES INC is the larger business by last-quarter revenue ($3.0B vs $1.7B, roughly 1.8× Clorox). Clorox runs the higher net margin — 11.4% vs 0.0%, a 11.4% gap on every dollar of revenue. On growth, LESAKA TECHNOLOGIES INC posted the faster year-over-year revenue change (0.2% vs 0.1%). Over the past eight quarters, LESAKA TECHNOLOGIES INC's revenue compounded faster (352.8% CAGR vs -4.1%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

CLX vs LSAK — Head-to-Head

Bigger by revenue
LSAK
LSAK
1.8× larger
LSAK
$3.0B
$1.7B
CLX
Growing faster (revenue YoY)
LSAK
LSAK
+0.1% gap
LSAK
0.2%
0.1%
CLX
Higher net margin
CLX
CLX
11.4% more per $
CLX
11.4%
0.0%
LSAK
Faster 2-yr revenue CAGR
LSAK
LSAK
Annualised
LSAK
352.8%
-4.1%
CLX

Income Statement — Q3 FY2026 vs Q1 FY2027

Metric
CLX
CLX
LSAK
LSAK
Revenue
$1.7B
$3.0B
Net Profit
$191.0M
$437.0K
Gross Margin
43.2%
Operating Margin
2.2%
Net Margin
11.4%
0.0%
Revenue YoY
0.1%
0.2%
Net Profit YoY
0.5%
EPS (diluted)
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
LSAK
LSAK
Q3 26
$3.0B
Q1 26
$1.7B
Q4 25
$1.7B
$178.7M
Q3 25
$171.4M
Q2 25
$2.0B
$168.5M
Q1 25
$1.7B
$161.4M
Q4 24
$1.7B
$176.2M
Q3 24
$1.8B
$153.6M
Net Profit
CLX
CLX
LSAK
LSAK
Q3 26
$437.0K
Q1 26
$191.0M
Q4 25
$157.0M
$3.6M
Q3 25
$-4.3M
Q2 25
$332.0M
$-28.4M
Q1 25
$186.0M
$-22.1M
Q4 24
$193.0M
$-32.5M
Q3 24
$99.0M
$-4.5M
Gross Margin
CLX
CLX
LSAK
LSAK
Q3 26
Q1 26
43.2%
Q4 25
43.2%
31.4%
Q3 25
30.9%
Q2 25
46.5%
28.9%
Q1 25
44.6%
27.5%
Q4 24
43.8%
25.7%
Q3 24
45.8%
22.6%
Operating Margin
CLX
CLX
LSAK
LSAK
Q3 26
2.2%
Q1 26
Q4 25
1.2%
Q3 25
0.2%
Q2 25
20.6%
-16.7%
Q1 25
15.2%
0.4%
Q4 24
14.1%
0.3%
Q3 24
10.0%
-0.0%
Net Margin
CLX
CLX
LSAK
LSAK
Q3 26
0.0%
Q1 26
11.4%
Q4 25
9.4%
2.0%
Q3 25
-2.5%
Q2 25
16.7%
-16.9%
Q1 25
11.2%
-13.7%
Q4 24
11.4%
-18.4%
Q3 24
5.6%
-3.0%
EPS (diluted)
CLX
CLX
LSAK
LSAK
Q3 26
Q1 26
$1.54
Q4 25
$1.29
$0.04
Q3 25
$-0.05
Q2 25
$2.68
$-0.40
Q1 25
$1.50
$-0.27
Q4 24
$1.54
$-0.40
Q3 24
$0.80
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
LSAK
LSAK
Cash + ST InvestmentsLiquidity on hand
$1.2B
$1.5B
Total DebtLower is stronger
$2.5B
$3.2B
Stockholders' EquityBook value
$92.0M
Total Assets
$6.4B
$11.5B
Debt / EquityLower = less leverage
27.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
LSAK
LSAK
Q3 26
$1.5B
Q1 26
$1.2B
Q4 25
$227.0M
$69.5M
Q3 25
$72.2M
Q2 25
$167.0M
$76.5M
Q1 25
$226.0M
$71.0M
Q4 24
$290.0M
$60.6M
Q3 24
$278.0M
$49.7M
Total Debt
CLX
CLX
LSAK
LSAK
Q3 26
$3.2B
Q1 26
$2.5B
Q4 25
$216.8M
Q3 25
$208.1M
Q2 25
$2.5B
$200.8M
Q1 25
$194.7M
Q4 24
$148.7M
Q3 24
$148.5M
Stockholders' Equity
CLX
CLX
LSAK
LSAK
Q3 26
Q1 26
$92.0M
Q4 25
$-125.0M
$180.6M
Q3 25
$170.4M
Q2 25
$321.0M
$161.6M
Q1 25
$27.0M
$185.2M
Q4 24
$-41.0M
$193.3M
Q3 24
$60.0M
$184.2M
Total Assets
CLX
CLX
LSAK
LSAK
Q3 26
$11.5B
Q1 26
$6.4B
Q4 25
$5.6B
$704.6M
Q3 25
$652.9M
Q2 25
$5.6B
$653.7M
Q1 25
$5.5B
$649.2M
Q4 24
$5.6B
$640.6M
Q3 24
$5.5B
$551.9M
Debt / Equity
CLX
CLX
LSAK
LSAK
Q3 26
Q1 26
27.03×
Q4 25
1.20×
Q3 25
1.22×
Q2 25
7.74×
1.24×
Q1 25
1.05×
Q4 24
0.77×
Q3 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons